Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 174

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 174
---
110% of the combined public offering price per share of Common Stock and accompanying May 2025 Warrant), except that the Placement Agent Warrants will not have any anti-dilution (other than protection against pro rata distributions or share combinations) provisions, will not include a provision to increase the number of shares underlying the Placement Agent Warrants upon the occurrence of a reverse stock split, will be immediately exercisable and will have a termination date that will be five years from the commencement of the sales pursuant to this offering. In accordance with FINRA Rule 5110(e), the Placement Agent may not sell, transfer, assign, pledge, or hypothecate the Placement Agent Warrant or the securities underlying such warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such warrants or the underlying securities for a period of 180 days following the date of commencement of sales pursuant to this public offering. The Placement Agent Warrants are registered on the registration statement of which this prospectus is a part. The form of the Placement Agent Warrants is included as an exhibit to this registration statement of which this prospectus forms a part. See “Plan of Distribution” below.

| 84 |

<div align='center'>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES</div>

The following is a general discussion of the material U.S. federal income tax considerations applicable to the ownership and disposition of shares of our Common Stock and the Pre-Funded Warrants and May 2025 Warrants acquired in this offering. The Pre-Funded Warrants and the May 2025 Warrants are collectively referred to as, the “Warrants”). This discussion is for general information only and is not tax advice. Accordingly, all prospective holders of our Common Stock and Warrants should consult their own tax advisors with respect to the U.S. federal, state, local and non-U.S. tax consequences of the purchase, ownership and disposition of our Common Stock and Warrants. This discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended, which we refer to as the Code, existing and proposed U.S. Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, all as in effect as of the date of this prospectus, all of which are subject to change or to differing interpretation, possibly with retroactive effect. Any change could alter the tax consequences described in this prospectus.